FFTY vs. PBE ETF Comparison

Comparison of Innovator IBD 50 Fund ETF (FFTY) to PowerShares Dynamic Biotech & Genome (PBE)
FFTY

Innovator IBD 50 Fund ETF

FFTY Description

The investment seeks long-term capital appreciation. Under normal circumstances, the fund will invest at least 80% of its net assets (plus borrowings for investment purposes) in companies included in the IBD® 50 Index. It is actively managed. Under normal circumstances, the fund will invest in a portfolio of U.S.-listed, exchange-traded equities. FFTY picks 50 leading growth companies that trade on US exchanges, potentially including ADRs. After screening out securities with extreme recent price movements, the universe is ranked by a composite of 11 different fundamental and technical metrics. The top 50 stocks are weighted in tiers, with more weight given to higher-ranking companies. Components of the index are reviewed on a weekly basis. Based on market-wide technical signals, FFTY may substitute half of its equity portfolio with Treasury bills. The index will remain half equity, half T-bills until a reversal signal occurs. Its worth noting that the funds high-turnover strategy could lead to poor tracking and/or taxable capital gains payouts.

Grade (RS Rating)

Last Trade

$26.30

Average Daily Volume

81,269

Number of Holdings *

50

* may have additional holdings in another (foreign) market
PBE

PowerShares Dynamic Biotech & Genome

PBE Description The PowerShares Dynamic Biotechnology & Genome Portfolio (Fund) is based on the Dynamic Biotech & Genome IntellidexSM Index (Intellidex Index). The Fund will normally invest at least 90% of its total assets in common stocks that comprise the Index. The Intellidex Index is designed to provide capital appreciation by thoroughly evaluating companies based on a variety of investment merit criteria, including price momentum, earnings momentum, quality, management action, and value. The Underlying Intellidex Index is comprised of common stocks of 30 US biotechnology and genome companies. These are companies that are principally engaged in the research, development, manufacture and marketing and distribution of various biotechnological products, services and processes and companies that benefit significantly from scientific and technological advances biotechnology and genetic engineering and reseach. The Fund and the Index are rebalanced and reconstituted quarterly in February, May, August and November.

Grade (RS Rating)

Last Trade

$60.39

Average Daily Volume

16,748

Number of Holdings *

30

* may have additional holdings in another (foreign) market
Performance
Period FFTY PBE
30 Days -5.29% -7.29%
60 Days -4.08% -8.31%
90 Days 5.12% -6.77%
12 Months 15.56% -1.99%
0 Overlapping Holdings
Symbol Grade Weight in FFTY Weight in PBE Overlap
FFTY Overweight 50 Positions Relative to PBE
Symbol Grade Weight
CELH C 3.81%
DKNG C 3.67%
FIX B 3.51%
VRT A 3.48%
ARM F 3.47%
NVDA B 3.44%
CRWD C 3.43%
GCT B 3.39%
CLSK B 3.36%
HIMS C 3.26%
MMYT B 3.15%
META D 3.11%
SWAV A 3.04%
NFLX D 3.01%
PR A 3.0%
ASND D 2.99%
TDW A 2.98%
ANET C 2.97%
RCL A 2.93%
WING A 2.82%
NTRA A 2.08%
FTAI B 2.06%
ETN A 2.05%
ACMR D 2.04%
COOP A 2.03%
NET C 2.02%
DASH B 2.0%
RYAAY C 1.98%
OWL A 1.98%
NVO B 1.97%
HUBS B 1.06%
FRPT C 1.04%
AXON B 1.0%
TBBB B 0.99%
SNPS C 0.99%
FROG C 0.99%
CRM D 0.99%
CDNS D 0.99%
DUOL B 0.97%
BLBD B 0.97%
AAON A 0.52%
KKR C 0.5%
FCNCA A 0.5%
TOST B 0.49%
KSPI A 0.49%
IBKR A 0.49%
CTAS A 0.49%
APPF B 0.49%
TCOM A 0.48%
LPG A 0.47%
FFTY Underweight 30 Positions Relative to PBE
Symbol Grade Weight
NBIX C -5.53%
BMRN D -5.43%
AMGN D -5.05%
VRTX C -5.04%
REGN D -5.01%
GILD F -4.87%
TECH D -4.74%
BIIB D -4.61%
MNKD C -3.3%
EXEL A -3.22%
COLL C -3.2%
UTHR B -3.12%
HALO D -3.09%
TGTX F -3.08%
CPRX D -3.05%
BPMC B -2.89%
ITCI B -2.87%
CLDX D -2.8%
PTCT D -2.79%
QGEN D -2.79%
DVAX F -2.73%
IONS D -2.69%
VCEL C -2.68%
RGEN D -2.45%
XENE D -2.42%
MYGN F -2.26%
VCYT F -2.26%
FOLD F -2.23%
ACAD F -1.92%
EYPT D -1.81%
Compare ETFs